Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) EBT (2016 - 2025)

Aethlon Medical (AEMD) has disclosed EBT for 15 consecutive years, with -$1.9 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, EBT rose 20.63% year-over-year to -$1.9 million, compared with a TTM value of -$9.0 million through Mar 2025, up 25.81%, and an annual FY2025 reading of -$13.7 million, down 12.24% over the prior year.
  • EBT was -$1.9 million for Q1 2025 at Aethlon Medical, down from -$1.8 million in the prior quarter.
  • Across five years, EBT topped out at -$1.8 million in Q4 2024 and bottomed at -$3.8 million in Q1 2022.
  • Average EBT over 5 years is -$2.7 million, with a median of -$2.6 million recorded in 2024.
  • The sharpest move saw EBT plummeted 82.54% in 2022, then surged 49.4% in 2024.
  • Year by year, EBT stood at -$2.5 million in 2021, then fell by 12.73% to -$2.8 million in 2022, then fell by 21.63% to -$3.5 million in 2023, then surged by 49.4% to -$1.8 million in 2024, then dropped by 8.9% to -$1.9 million in 2025.
  • Business Quant data shows EBT for AEMD at -$1.9 million in Q1 2025, -$1.8 million in Q4 2024, and -$2.8 million in Q3 2024.